Clinical Trial Update: Oxaliplatin in Treating Patients With Advanced Head and Neck Cancer [Phase 2]

View source ↗

Summary

A completed Phase 2 clinical trial evaluated oxaliplatin in patients with advanced head and neck cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Eloxatin (oxaliplatin)

Snippet

Sponsor: Ohio State University Comprehensive Cancer Center | Conditions: Head and Neck Cancer | Phase 2 | Status: COMPLETED